Investor Overview

Webcast ImageWebcast
Selecta Biosciences, Inc. at UBS Global Healthcare Conference (Replay)
May 23, 2017 at 11:00 a.m. ET
Selecta Biosciences, Inc. at UBS Global Healthcare Conference
Tuesday, May 23, 2017 11:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Selecta Biosciences is a clinical-stage biopharmaceutical company developing targeted immunotherapies and vaccines that are designed to modulate immune responses to treat and prevent disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP™) platform has the potential to create a new paradigm in immunology and may enable a novel approach for selectively targeting the immune system to effectively and safely treat and prevent rare and serious dis... View more »

Recent News
View all press releases »
Presentations
Download DocumentationMay 22, 2017
Selecta May 2017 Investor Presentation
Download DocumentationMay 12, 2017
ASGCT 2017 MMA Presentation
Download DocumentationMay 12, 2017
ASGCT 2017 Repeat Dosing Presentation
Download DocumentationMay 11, 2017
Selecta Q1 2017 Conference Call Presentation
Upcoming Events
There are currently no events scheduled.
View all events »
Stock Quote
NASDAQ GS :  SELB (Common Stock)
$14.05
+ 0.53 (3.92%)
Stock chart for: SELB.O.  Currently trading at $14.05 with a 52 week high of $28.00 and a 52 week low of $10.26.
Data as of May 26, 2017 4:00 p.m. ET
Minimum 15 minute delay
Refresh quote
IR Contact
Jason Fredette
Selecta Biosciences
Phone: 1 617 231 8078
E-mail: JFredette@selectabio.com

Data provided by Nasdaq. Minimum 15 minutes delayed.
Back to Top